{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T08:24:45Z","timestamp":1768983885068,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2001,7,17]],"date-time":"2001-07-17T00:00:00Z","timestamp":995328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,7,17]],"date-time":"2001-07-17T00:00:00Z","timestamp":995328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/cvm-2-4-180","type":"journal-article","created":{"date-parts":[[2002,9,26]],"date-time":"2002-09-26T12:07:27Z","timestamp":1033042047000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Systematic adjudication of myocardial infarction end-points in an international clinical trial"],"prefix":"10.1186","volume":"2","author":[{"given":"Kenneth W","family":"Mahaffey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martijn","family":"Akkerhuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal S","family":"Kleiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa G","family":"Berdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian S","family":"Crenshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara E","family":"Tardiff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher B","family":"Granger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"DeJong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manju","family":"Bhapkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr","family":"Widimsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram\u00f3n","family":"Corbalon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry L","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaap W","family":"Deckers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten L","family":"Simoons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric J","family":"Topol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M","family":"Califf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the PURSUIT Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2001,7,17]]},"reference":[{"key":"69_CR1","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1056\/NEJM199609123351103","volume":"335","author":"The GUSTO-IIb Investigators","year":"1996","unstructured":"The GUSTO-IIb Investigators: A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med. 1996, 335: 775-782. 10.1056\/NEJM199609123351103.","journal-title":"N Engl J Med"},{"key":"69_CR2","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1056\/NEJM199404073301402","volume":"330","author":"The EPIC Investigators","year":"1994","unstructured":"The EPIC Investigators: Use of a monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa receptor in high-risk coronary angioplasty. N Engl J Med. 1994, 330: 956-961. 10.1056\/NEJM199404073301402.","journal-title":"N Engl J Med"},{"key":"69_CR3","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1056\/NEJM199706123362401","volume":"336","author":"The EPILOG Investigators","year":"1997","unstructured":"The EPILOG Investigators: Platelet glycoprotein IIb\/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med. 1997, 336: 1689-1696. 10.1056\/NEJM199706123362401.","journal-title":"N Engl J Med"},{"key":"69_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","volume":"308","author":"The Antiplatelet Trialists' Collaboration","year":"1994","unstructured":"The Antiplatelet Trialists' Collaboration: Collaborative overview of randomised trials of antiplatelet therapy I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J. 1994, 308: 81-106.","journal-title":"Br Med J"},{"key":"69_CR5","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/01.CIR.94.5.911","volume":"94","author":"EM Antman","year":"1996","unstructured":"Antman EM, for the TIMI 9B Investigators: Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial. Circulation. 1996, 94: 911-922.","journal-title":"Circulation"},{"key":"69_CR6","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1056\/NEJM199808133390704","volume":"339","author":"The PURSUIT Investigators","year":"1998","unstructured":"The PURSUIT Investigators: Inhibition of platelet glycoprotein IIb\/IIIa with eptifibatide in patients with acute coronary syndromes without persistent ST-segment elevation: a randomized, placebo-controlled, clinical trial. N Engl J Med. 1998, 339: 436-443. 10.1056\/NEJM199808133390704.","journal-title":"N Engl J Med"},{"key":"69_CR7","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1056\/NEJM199805213382103","volume":"338","author":"The PRISM Investigators","year":"1998","unstructured":"The PRISM Investigators: A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med. 1998, 338: 1498-1505. 10.1056\/NEJM199805213382103.","journal-title":"N Engl J Med"},{"key":"69_CR8","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","volume":"338","author":"The PRISM PLUS Investigators","year":"1998","unstructured":"The PRISM PLUS Investigators: Inhibition of the platelet glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med. 1998, 338: 1488-1497. 10.1056\/NEJM199805213382102.","journal-title":"N Engl J Med"},{"key":"69_CR9","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/S0140-6736(96)10172-0","volume":"349","author":"The IMPACT-II Investigators","year":"1997","unstructured":"The IMPACT-II Investigators: Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention. Lancet. 1997, 349: 1422-1428. 10.1016\/S0140-6736(96)10172-0.","journal-title":"Lancet"},{"key":"69_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0140-6736(98)06113-3","volume":"352","author":"The EPISTENT Investigators","year":"1998","unstructured":"The EPISTENT Investigators: Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb\/IIIa blockade. Lancet. 1998, 352: 87-92. 10.1016\/S0140-6736(98)06113-3.","journal-title":"Lancet"},{"key":"69_CR11","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/S0140-6736(96)10452-9","volume":"349","author":"The CAPTURE Investigators","year":"1997","unstructured":"The CAPTURE Investigators: Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina. Lancet. 1997, 349: 1429-1435. 10.1016\/S0140-6736(96)10452-9.","journal-title":"Lancet"},{"key":"69_CR12","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1056\/NEJM198012183032534","volume":"303","author":"R Temple","year":"1980","unstructured":"Temple R, Pledger GW: The FDA's critique of the anturane reinfarction trial. N Engl J Med. 1980, 303: 1488-1492.","journal-title":"N Engl J Med"},{"key":"69_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/0735-1097(95)00482-3","volume":"27","author":"AE Epstein","year":"1996","unstructured":"Epstein AE, Carlson MD, Fogoros RN, Higgins SL, Venditti FJ: Classification of death in antiarrhythmia trials. J Am Coll Cardiol. 1996, 27: 433-442. 10.1016\/0735-1097(95)00482-3.","journal-title":"J Am Coll Cardiol"},{"key":"69_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0197-2456(84)90027-8","volume":"5","author":"RD Remington","year":"1984","unstructured":"Remington RD: Who should code cause of death in a clinical trial?. Contr Clin Trials. 1984, 5: 241-244. 10.1016\/0197-2456(84)90027-8.","journal-title":"Contr Clin Trials"},{"key":"69_CR15","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/0895-4356(90)90094-6","volume":"43","author":"MA Moussa","year":"1990","unstructured":"Moussa MA, Shafie MZ, Khogali MM, el-Sayed AM, Sugathan TN, Cherian G, Abdel-Khalik AZ, Garada MT, Verma D: Reliability of death certificate diagnoses. J Clin Epidemiol. 1990, 43: 1285-1295.","journal-title":"J Clin Epidemiol"},{"key":"69_CR16","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1093\/oxfordjournals.eurheartj.a015074","volume":"17","author":"R Narang","year":"1996","unstructured":"Narang R, Clelan GF, Erhardt L, Ball SG, Coats AJ, Cowley AJ, Dargie HJ, Hall AS, Hampton JR, Poole-Wilson PA: Mode of death in chronic heart failure. A request and proposition for more accurate classification. Eur Heart J. 1996, 17: 1390-1403.","journal-title":"Eur Heart J"},{"key":"69_CR17","doi-asserted-by":"publisher","first-page":"250A","DOI":"10.1016\/S0735-1097(96)81883-3","volume":"27","author":"KW Mahaffey","year":"1996","unstructured":"Mahaffey KW, Granger CB, Woodlief L, Tardiff BE, Bandy S, Califf RM: Centralized systematic adjudication of clinical end-points in multicenter trials of acute coronary syndromes identifies patients at high risk for adverse clinical outcomes [abstract]. J Am Coll Cardiol. 1996, 27: 250A-10.1016\/S0735-1097(96)81883-3.","journal-title":"J Am Coll Cardiol"},{"key":"69_CR18","first-page":"25S","volume":"17","author":"BE Tardiff","year":"1996","unstructured":"Tardiff BE, Mahaffey KW, Sigmon KN, Tcheng JE, Karnash SL, Lee KL, Granger CM, Califf RM: Differences in endpoint identification by investigators versus independent review [abstract]. Contr Clin Trials. 1996, 17: 25S-","journal-title":"Contr Clin Trials"},{"key":"69_CR19","doi-asserted-by":"publisher","first-page":"136S","DOI":"10.1016\/0197-2456(96)84693-9","volume":"17","author":"KW Mahaffey","year":"1996","unstructured":"Mahaffey KW, Tardiff BE, Granger CB, Woodlief LW, Clapp-Channing NE, Karnash SL, McCants B, Raney M, Lee KL, Califf RM: Comparison of investigator and central events review of myocardial infarction rates as a means to improve events classification: results from GUSTO-IIa [abstract]. Contr Clin Trials. 1996, 17: 136S-10.1016\/0197-2456(96)84693-9.","journal-title":"Contr Clin Trials"},{"key":"69_CR20","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/1047-2797(94)00093-9","volume":"5","author":"DG Ives","year":"1995","unstructured":"Ives DG, Fitzpatrick AL, Bild DE, Psaty BM, Kuller LH, Crowley PM, Cruise RG, Theroux S: Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol. 1995, 5: 278-285. 10.1016\/1047-2797(94)00093-9.","journal-title":"Ann Epidemiol"},{"key":"69_CR21","doi-asserted-by":"publisher","first-page":"410A","DOI":"10.1016\/S0735-1097(97)87367-6","volume":"29","author":"KW Mahaffey","year":"1997","unstructured":"Mahaffey KW, Granger CB, Tardiff BE, Woodlief L, Lee KL, Weaver WD, Topol EJ, Califf RM, for the GUSTO-IIb Investigators: Endpoint adjudication by clinical events committee can impact the statistical outcome of a clinical trial: results from GUSTO-IIb [abstract]. J Am Coll Cardiol. 1997, 29: 410A-","journal-title":"J Am Coll Cardiol"},{"key":"69_CR22","doi-asserted-by":"publisher","first-page":"184A","DOI":"10.1016\/S0735-1097(98)81442-3","volume":"31","author":"KW Mahaffey","year":"1998","unstructured":"Mahaffey KW, Tardiff BE, Granger CB, Lee KL, Harrington RA, Topol EJ, Califf RM: Disagreement between site investigators and clinical event committees is common and can affect trial results [abstract]. J Am Coll Cardiol. 1998, 31: 184A-185A. 10.1016\/S0735-1097(98)81442-3.","journal-title":"J Am Coll Cardiol"},{"key":"69_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1053\/euhj.1997.0573","volume":"19","author":"KW Mahaffey","year":"1998","unstructured":"Mahaffey KW, Akkerhuis M, Boersma H, Tardiff BE, Harrington RA, Topol EJ, Califf RM: The identification of MI in clinical trials is difficult and there is substantial difference between the assessment by site investigators and a clinical events committee: results from PURSUIT [abstract]. Eur Heart J. 1998, 19: 55-10.1053\/euhj.1997.0573.","journal-title":"Eur Heart J"},{"key":"69_CR24","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1053\/euhj.1998.1351","volume":"20","author":"U N\u00e4slund","year":"1999","unstructured":"N\u00e4slund U, Grip L, Fischer-Hansen J, Gundersen T, Lehto S, Wal-lentin L: The impact of an end-point committee in a large mul-ticentre, randomised, placebo-controlled clinical trial. Eur Heart J. 1999, 20: 771-777. 10.1053\/euhj.1998.1351.","journal-title":"Eur Heart J"},{"key":"69_CR25","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1056\/NEJM199309023291001","volume":"329","author":"The GUSTO Investigators","year":"1993","unstructured":"The GUSTO Investigators: An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993, 329: 673-682. 10.1056\/NEJM199309023291001.","journal-title":"N Engl J Med"},{"key":"69_CR26","first-page":"349","volume":"2","author":"ISIS-2 (Second International Study of Infarct Survival) Collaborative Group","year":"1988","unstructured":"ISIS-2 (Second International Study of Infarct Survival) Collaborative Group: Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 case of suspected acute myocardial infarction: ISIS-2. Lancet. 1988, 2: 349-360.","journal-title":"Lancet"},{"key":"69_CR27","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(86)92368-8","volume":"1","author":"Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Mio-cardico (GISSI)","year":"1986","unstructured":"Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Mio-cardico (GISSI): Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986, 1: 397-401. 10.1016\/S0140-6736(86)92368-8.","journal-title":"Lancet"},{"key":"69_CR28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0735-1097(97)00506-8","volume":"31","author":"RM Califf","year":"1998","unstructured":"Califf RM, Abdelmeguid AE, Kuntz R, Popma JJ, Davidson CJ, Cohen EA, Kleiman NS, Mahaffey KW, Topol EJ, Pepine CJ, Lipicky RJ, Granger CB, Harrington RA, Tardiff BE, Crenshaw BS, Bauman RP, Zuckerman BD, Chaitman BR, Bittl JA, Ohman EM: Myonecrosis after revascularization procedures. J Am Coll Cardiol. 1998, 31: 241-251. 10.1016\/S0735-1097(97)00506-8.","journal-title":"J Am Coll Cardiol"},{"key":"69_CR29","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1161\/01.CIR.89.4.1545","volume":"89","author":"Thrombolysis in Myocardial Ischemia (TIMI) Study Group","year":"1994","unstructured":"Thrombolysis in Myocardial Ischemia (TIMI) Study Group: Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB Trial. Circulation. 1994, 89: 1545-1556.","journal-title":"Circulation"},{"key":"69_CR30","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1056\/NEJM199209033271001","volume":"327","author":"The SAVE Investigators","year":"1992","unstructured":"The SAVE Investigators: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival And Ventricular Enlargement trial. N Engl J Med. 1992, 327: 669-677.","journal-title":"N Engl J Med"},{"key":"69_CR31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJM199307223290401","volume":"329","author":"The CAVEAT Study Group","year":"1993","unstructured":"The CAVEAT Study Group: A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med. 1993, 329: 221-227. 10.1056\/NEJM199307223290401.","journal-title":"N Engl J Med"},{"key":"69_CR32","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1161\/01.CIR.96.5.1445","volume":"96","author":"The RESTORE Study Group","year":"1997","unstructured":"The RESTORE Study Group: Effects of platelet glycoprotein IIb\/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation. 1997, 96: 1445-1453.","journal-title":"Circulation"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cvm-2-4-180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/cvm-2-4-180\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cvm-2-4-180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T15:06:10Z","timestamp":1714057570000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/cvm-2-4-180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7,17]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2001,8]]}},"alternative-id":["69"],"URL":"https:\/\/doi.org\/10.1186\/cvm-2-4-180","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,7,17]]},"assertion":[{"value":"15 March 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2001","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2001","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2001","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"180"}}